On 28 March 2018, the FEAM European Biomedical Policy Forum organised a round table discussion on use of animals in scientific research, which was chaired by Professor André Parodi, Honorary President of the French National Academy of Medicine and of the French Veterinary Academy. The summary report of the event is now available.
The objective of the round table was to discuss the recommendations of the European Commission review report of the Directive 2010/63/EU on the protection of animals used for scientific purposes to inform policy discussion in EU institutions and to identify recommendations for the users’ community on this basis.
The round table brought together representatives from the diverse sectors within the biomedical community (academia, industry, research organisations, medical charities, etc.) and policy-makers.
The meeting highlighted that there is overwhelming agreement that Europe has appropriate and detailed legislation regulating the use of animals in scientific research, that adapts to and encourages scientific progress. However, focus is required on ensuring that the Directive 2010/63/EU is implemented in a way that focuses on welfare impacts and avoids duplicative or unnecessary processes and on sharing of good practices, in particular on issues where the scientific community can do more to deliver on 3Rs and quality of science.
Conclusions also show that successful implementation of the Directive is a shared responsibility. The round table identified opportunities to join forces and work together, as the Directive 2010/63/EU cannot be successfully implemented by organisations or individuals working in isolation.
The FEAM European Biomedical Policy Forum provides a platform for discussion on key policy issues for the biomedical community.
The Forum is an initiative from the Federation of European Academies of Medicine (FEAM). It aims to bring together representatives from academia, research charities, industry, European and national trade associations and professional bodies, regulators, public health bodies, and patient and consumers groups. If you would like further information on the FEAM European Biomedical Policy Forum or becoming a partner, please contact email@example.com